NASDAQ : QTTB
Q32 Bio Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 8.87 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 264.06M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Q32 Bio Inc. (QTTB) reported revenue of 53.74M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 53.74M | 53.74M | -6.65M | 6.65M | ||
| Cost of Revenue | 14.35M | 19.16M | 48.14M | 31.73M | 35.81M | 29.93M |
| Gross Profit | 39.39M | 34.58M | -48.14M | -38.38M | -29.16M | -29.93M |
| Selling, General & Admin | 17.93M | 17.68M | 17.96M | 9.88M | 10.06M | 6.76M |
| Operating Expenses | 17.93M | 17.68M | 17.96M | 9.88M | 10.06M | 6.76M |
| Operating Income | 21.46M | 16.90M | -66.10M | -48.26M | -39.23M | -36.69M |
| Interest Expense | -900.00K | -1.10M | -1.40M | -2.00M | ||
| Interest & Investment Income | 1.78M | 2.20M | 3.90M | |||
| Earnings From Equity Investments | -1.62M | |||||
| Other Non Operating Income (Expenses) | -75.00K | 156.00K | 2.30M | 3.02M | -3.52M | -324.00K |
| EBT Excluding Unusual Items | 22.27M | 18.16M | -62.93M | -47.23M | -42.75M | -37.02M |
| Gain (Loss) on Sale of Investments | -74.00K | -74.00K | -675.00K | |||
| Gain (Loss) on Sale of Assets | 11.74M | 11.74M | ||||
| Other Unusual Items | -147.00K | 15.89M | -6.19M | |||
| Pretax Income | 33.79M | 29.82M | -47.71M | -53.42M | -42.75M | -37.02M |
| Income Tax Expense | 21.00K | 318.00K | 62.00K | 547.00K | ||
| Net Income | 33.79M | 29.82M | -47.73M | -53.74M | -42.81M | -37.56M |
| Net Income to Common | 33.79M | 29.82M | -47.73M | -53.74M | -42.81M | -37.56M |
| Shares Outstanding (Basic) | 14.83M | 12.30M | 9.32M | 349.06K | 7.03M | 6.47M |
| Shares Outstanding (Diluted) | 14.85M | 12.31M | 9.66M | 349.06K | 7.03M | 6.47M |
| EPS (Basic) | 2.28 | 2.42 | -5.12 | -153.96 | -6.09 | -5.81 |
| EPS (Diluted) | 2.27 | 2.42 | -6.58 | -153.96 | -6.09 | -5.81 |
| Free Cash Flow | -19.83M | -33.54M | -67.79M | -18.68M | -13.44M | -33.14M |
| Free Cash Flow Per Share | -1.33 | -2.72 | -7.02 | -53.52 | -1.91 | -5.12 |
| Gross Margin | 73.30% | 64.35% | ||||
| Operating Margin | 39.94% | 31.45% | -589.76% | |||
| Profit Margin | 62.87% | 55.49% | -643.65% | |||
| Free Cash Flow Margin | -36.90% | -62.42% | -202.10% | |||
| EBITDA | 21.82M | 17.29M | -65.61M | -47.76M | -38.85M | -36.65M |
| EBITDA Margin | 40.60% | 32.18% | ||||
| D&A For EBITDA | 356.00K | 391.00K | 487.00K | 499.00K | 370.00K | 47.00K |
| EBIT | 21.46M | 16.90M | -66.10M | -48.26M | -39.23M | -36.69M |
| EBIT Margin | 39.94% | 31.45% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 106.27M | 48.30M | 77.97M | 25.62M | 43.89M | 32.25M |
| Cash & Short-Term Investments | 106.27M | 48.30M | 77.97M | 25.62M | 43.89M | 32.25M |
| Other Receivables | 555.00K | 555.00K | 555.00K | 755.00K | 1.06M | 909.00K |
| Receivables | 555.00K | 555.00K | 555.00K | 755.00K | 1.06M | 909.00K |
| Prepaid Expenses | 875.00K | 1.34M | 2.96M | 2.26M | 1.75M | 769.00K |
| Other Current Assets | 1.95M | 4.86M | 396.00K | 83.00K | 146.00K | 73.00K |
| Total Current Assets | 109.65M | 55.05M | 81.88M | 28.72M | 46.85M | 34.00M |
| Property, Plant & Equipment | 5.57M | 6.08M | 7.09M | 8.08M | 9.17M | 203.00K |
| Long-Term Investments | 2.60M | |||||
| Other Long-Term Assets | 647.00K | 647.00K | 763.00K | 10.26M | 5.75M | 950.00K |
| Total Assets | 115.87M | 61.78M | 92.33M | 47.06M | 61.77M | 35.15M |
| Accounts Payable | 1.56M | 879.00K | 2.99M | 3.47M | 1.44M | 2.68M |
| Accrued Expenses | 3.10M | 3.54M | 6.87M | 8.91M | 8.46M | 4.54M |
| Current Portion of Long-Term Debt | 6.24M | 3.10M | 878.00K | 32.40M | ||
| Current Portion of Leases | 735.00K | 693.00K | 612.00K | 538.00K | 471.00K | |
| Current Income Taxes Payable | 316.00K | 570.00K | ||||
| Current Unearned Revenue | 14.53M | |||||
| Other Current Liabilities | 2.90M | |||||
| Total Current Liabilities | 5.40M | 11.35M | 16.46M | 14.11M | 57.87M | 7.22M |
| Long-Term Debt | 3.47M | 9.56M | 43.18M | 5.07M | 4.97M | |
| Long-Term Leases | 4.56M | 4.94M | 5.64M | 6.25M | 6.79M | |
| Long-Term Unearned Revenue | 11.32M | |||||
| Other Long-Term Liabilities | 55.00M | 55.00M | 728.00K | |||
| Total Liabilities | 9.96M | 19.76M | 86.66M | 118.53M | 81.04M | 12.92M |
| Common Stock | 3.00K | 2.00K | 2.00K | 1.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 327.45M | 247.00M | 240.49M | 4.16M | 2.62M | 1.32M |
| Retained Earnings | -221.55M | -204.99M | -234.81M | -187.08M | -133.34M | -90.53M |
| Total Common Equity | 105.91M | 42.01M | 5.67M | -182.92M | -130.71M | -89.21M |
| Shareholders' Equity | 105.91M | 42.01M | 5.67M | -71.48M | -19.27M | 22.23M |
| Total Liabilities & Equity | 115.87M | 61.78M | 92.33M | 47.06M | 61.77M | 35.15M |
| Total Debt | 5.30M | 15.34M | 18.90M | 50.84M | 44.73M | 4.97M |
| Net Cash (Debt) | 100.97M | 32.95M | 59.06M | -25.22M | -838.00K | 27.27M |
| Net Cash Per Share | 6.80 | 2.68 | 6.12 | -72.26 | -0.12 | 4.21 |
| Filing Date Shares Outstanding | 29.77M | 14.63M | 12.20M | 11.93M | 7.14M | 6.47M |
| Total Common Shares Outstanding | 23.74M | 12.86M | 12.20M | 7.47M | 7.14M | 6.47M |
| Working Capital | 104.25M | 43.70M | 65.41M | 14.61M | -11.01M | 26.78M |
| Book Value Per Share | 4.46 | 3.27 | 0.47 | -24.48 | -18.31 | -13.79 |
| Tangible Book Value | 105.91M | 42.01M | 5.67M | -182.92M | -130.71M | -89.21M |
| Tangible Book Value Per Share | 4.46 | 3.27 | 0.47 | -24.48 | -18.31 | -13.79 |
| Machinery | 1.82M | 1.82M | 1.82M | 1.81M | 1.81M | 305.00K |
| Leasehold Improvements | 1.00M | 1.00M | 1.00M | 940.00K | 935.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 33.79M | 29.82M | -47.73M | -53.74M | -42.81M | -37.56M |
| Depreciation & Amortization | 356.00K | 391.00K | 487.00K | 499.00K | 370.00K | 47.00K |
| Other Amortization | 180.00K | 180.00K | 194.00K | 87.00K | 100.00K | 102.00K |
| Loss (Gain) From Sale of Assets | -11.74M | -11.74M | 23.00K | |||
| Loss (Gain) From Sale of Investments | 74.00K | 454.00K | ||||
| Loss (Gain) on Equity Investments | 1.62M | |||||
| Stock-Based Compensation | 5.88M | 5.25M | 4.39M | 1.43M | 1.24M | 753.00K |
| Other Operating Activities | -53.08M | -53.49M | -17.49M | 6.74M | 3.18M | |
| Change in Accounts Payable | 655.00K | -2.11M | -1.04M | 2.03M | -1.24M | 1.10M |
| Change in Unearned Revenue | -25.85M | 25.85M | ||||
| Change in Other Net Operating Assets | 4.13M | -1.93M | -8.59M | 50.13M | 2.33M | 2.58M |
| Operating Cash Flow | -19.83M | -33.54M | -67.72M | -18.68M | -10.96M | -32.98M |
| Capital Expenditures | -75.00K | -5.00K | -2.48M | -157.00K | ||
| Sale of Property, Plant & Equipment | 7.00M | 7.00M | 19.00K | |||
| Investment in Securities | 20.00M | |||||
| Investing Cash Flow | 7.00M | 7.00M | 19.93M | -5.00K | -2.47M | -157.00K |
| Long-Term Debt Issued | 7.00M | 5.50M | 30.00M | |||
| Long-Term Debt Repaid | -3.12M | -5.20M | ||||
| Net Debt Issued (Repaid) | -12.95M | -3.12M | 7.00M | 300.00K | 30.00M | |
| Issuance of Common Stock | 77.21M | 43.69M | 106.00K | 69.00K | 115.00K | |
| Other Financing Activities | 44.44M | |||||
| Financing Cash Flow | 64.27M | -3.12M | 95.14M | 406.00K | 30.07M | 20.11M |
| Net Cash Flow | 51.44M | -29.67M | 47.35M | -18.28M | 16.65M | -13.03M |
| Free Cash Flow | -19.83M | -33.54M | -67.79M | -18.68M | -13.44M | -33.14M |
| Free Cash Flow Margin | -36.90% | -62.42% | -202.10% | |||
| Free Cash Flow Per Share | -1.33 | -2.72 | -7.02 | -53.52 | -1.91 | -5.12 |
| Levered Free Cash Flow | 19.39M | 4.52M | -37.95M | -41.84M | -8.73M | |
| Unlevered Free Cash Flow | 19.77M | 5.03M | -37.27M | -40.68M | -8.83M | |
| Cash Interest Paid | 863.00K | 961.00K | 856.00K | |||
| Change in Working Capital | 4.78M | -4.04M | -9.64M | 26.32M | 26.94M | 3.68M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 265.25M | 40.85M | 41.90M | |||
| Enterprise Value | 164.27M | 8.84M | -25.07M | |||
| Last Close Price | 8.91 | 3.32 | 3.44 | |||
| PE Ratio | 3.92 | 1.37 | ||||
| PS Ratio | 4.94 | 0.76 | ||||
| PB Ratio | 2.00 | 0.97 | 7.38 | |||
| P/TBV Ratio | 2.50 | 0.97 | 7.38 | |||
| EV/Sales Ratio | 3.06 | 0.16 | ||||
| EV/EBITDA Ratio | 7.53 | 0.51 | ||||
| EV/EBIT Ratio | 7.65 | 0.52 | ||||
| Debt / Equity Ratio | 0.05 | 0.36 | 3.33 | -0.71 | -2.32 | 0.22 |
| Debt / EBITDA Ratio | 0.23 | 0.81 | ||||
| Net Debt / Equity Ratio | -0.95 | -0.78 | -10.41 | -0.35 | -0.04 | -1.23 |
| Net Debt / EBITDA Ratio | -4.63 | -1.91 | 0.90 | -0.53 | -0.02 | 0.74 |
| Net Debt / FCF Ratio | 5.09 | 0.98 | 0.87 | -1.35 | -0.06 | 0.82 |
| Asset Turnover | 0.59 | 0.70 | 0.14 | |||
| Quick Ratio | 19.78 | 4.31 | 4.77 | 1.87 | 0.78 | 4.59 |
| Current Ratio | 20.30 | 4.85 | 4.97 | 2.04 | 0.81 | 4.71 |
| Return on Equity (ROE) | 72.14% | 125.06% | -2,884.70% | |||
| Return on Assets (ROA) | 14.74% | 13.71% | -59.28% | -55.42% | -50.59% | |
| Return on Capital Employed (ROCE) | 19.40% | 33.50% | -87.10% | -146.50% | -1,003.50% | -131.40% |
| Earnings Yield | 25.50% | 73.00% | -113.92% | |||
| FCF Yield | -7.48% | -82.11% | -161.78% | |||
| Buyback Yield / Dilution | -21.91% | -27.51% | -2,666.77% | 95.03% | -8.57% |